These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 11228531

  • 1. Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both two-and three-dimensional models.
    Carlin S, Cunningham SH, Boyd M, McCluskey AG, Mairs RJ.
    Cancer Gene Ther; 2000 Dec; 7(12):1529-36. PubMed ID: 11228531
    [Abstract] [Full Text] [Related]

  • 2. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.
    Spitzweg C, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC.
    Cancer Res; 2000 Nov 15; 60(22):6526-30. PubMed ID: 11103823
    [Abstract] [Full Text] [Related]

  • 3. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene.
    Mandell RB, Mandell LZ, Link CJ.
    Cancer Res; 1999 Feb 01; 59(3):661-8. PubMed ID: 9973215
    [Abstract] [Full Text] [Related]

  • 4. Establishment and characterization of a breast cancer cell line expressing Na+/I- symporters for radioiodide concentrator gene therapy.
    Nakamoto Y, Saga T, Misaki T, Kobayashi H, Sato N, Ishimori T, Kosugi S, Sakahara H, Konishi J.
    J Nucl Med; 2000 Nov 01; 41(11):1898-904. PubMed ID: 11079502
    [Abstract] [Full Text] [Related]

  • 5. The rat sodium iodide symporter gene permits more effective radioisotope concentration than the human sodium iodide symporter gene in human and rodent cancer cells.
    Heltemes LM, Hagan CR, Mitrofanova EE, Panchal RG, Guo J, Link CJ.
    Cancer Gene Ther; 2003 Jan 01; 10(1):14-22. PubMed ID: 12489024
    [Abstract] [Full Text] [Related]

  • 6. Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene.
    Klutz K, Russ V, Willhauck MJ, Wunderlich N, Zach C, Gildehaus FJ, Göke B, Wagner E, Ogris M, Spitzweg C.
    Clin Cancer Res; 2009 Oct 01; 15(19):6079-86. PubMed ID: 19789324
    [Abstract] [Full Text] [Related]

  • 7. Sodium iodide symporter/radioactive iodine system has more efficient antitumor effect in three-dimensional spheroids.
    Mitrofanova E, Hagan C, Qi J, Seregina T, Link C.
    Anticancer Res; 2003 Oct 01; 23(3B):2397-404. PubMed ID: 12894520
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Radioiodide treatment after sodium iodide symporter gene transfer is a highly effective therapy in neuroendocrine tumor cells.
    Schipper ML, Weber A, Béhé M, Göke R, Joba W, Schmidt H, Bert T, Simon B, Arnold R, Heufelder AE, Behr TM.
    Cancer Res; 2003 Mar 15; 63(6):1333-8. PubMed ID: 12649195
    [Abstract] [Full Text] [Related]

  • 10. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.
    Scholz IV, Cengic N, Baker CH, Harrington KJ, Maletz K, Bergert ER, Vile R, Göke B, Morris JC, Spitzweg C.
    Gene Ther; 2005 Feb 15; 12(3):272-80. PubMed ID: 15510175
    [Abstract] [Full Text] [Related]

  • 11. Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells.
    Li W, Tan J, Wang P, Wu P.
    Cancer Biother Radiopharm; 2011 Aug 15; 26(4):443-51. PubMed ID: 21797672
    [Abstract] [Full Text] [Related]

  • 12. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
    Willhauck MJ, Sharif Samani BR, Klutz K, Cengic N, Wolf I, Mohr L, Geissler M, Senekowitsch-Schmidtke R, Göke B, Morris JC, Spitzweg C.
    Gene Ther; 2008 Feb 15; 15(3):214-23. PubMed ID: 17989705
    [Abstract] [Full Text] [Related]

  • 13. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
    Mitrofanova E, Unfer R, Vahanian N, Link C.
    Gene Ther; 2006 Jul 15; 13(13):1052-6. PubMed ID: 16525480
    [Abstract] [Full Text] [Related]

  • 14. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.
    Kakinuma H, Bergert ER, Spitzweg C, Cheville JC, Lieber MM, Morris JC.
    Cancer Res; 2003 Nov 15; 63(22):7840-4. PubMed ID: 14633711
    [Abstract] [Full Text] [Related]

  • 15. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter.
    Dwyer RM, Bergert ER, O'connor MK, Gendler SJ, Morris JC.
    Clin Cancer Res; 2005 Feb 15; 11(4):1483-9. PubMed ID: 15746050
    [Abstract] [Full Text] [Related]

  • 16. In vitro cytotoxicity of (211)at-astatide and (131)I-iodide to glioma tumor cells expressing the sodium/iodide symporter.
    Carlin S, Akabani G, Zalutsky MR.
    J Nucl Med; 2003 Nov 15; 44(11):1827-38. PubMed ID: 14602867
    [Abstract] [Full Text] [Related]

  • 17. Radioiodine therapy of hepatoma using targeted transfer of the human sodium/iodide symporter gene.
    Chen L, Altmann A, Mier W, Eskerski H, Leotta K, Guo L, Zhu R, Haberkorn U.
    J Nucl Med; 2006 May 15; 47(5):854-62. PubMed ID: 16644756
    [Abstract] [Full Text] [Related]

  • 18. Noradrenaline transporter gene transfer for radiation cell kill by 131I meta-iodobenzylguanidine.
    Boyd M, Cunningham SH, Brown MM, Mairs RJ, Wheldon TE.
    Gene Ther; 1999 Jun 15; 6(6):1147-52. PubMed ID: 10455418
    [Abstract] [Full Text] [Related]

  • 19. Combination therapy and noninvasive imaging with a dual therapeutic vector expressing MDR1 short hairpin RNA and a sodium iodide symporter.
    Park SY, Kwak W, Thapa N, Jung MY, Nam JO, So IS, Kim SY, Yoo J, Lee J, Kim IS.
    J Nucl Med; 2008 Sep 15; 49(9):1480-8. PubMed ID: 18703598
    [Abstract] [Full Text] [Related]

  • 20. Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line.
    Jeong H, Kim YR, Kim KN, Choe JG, Chung JK, Kim MK.
    Nucl Med Biol; 2006 Oct 15; 33(7):875-82. PubMed ID: 17045167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.